View in EDS

Clinical Pharmacokinetic Assessment of Lazertinib in Healthy Adult Participants: Effects of GSTM1 Genotype.

Saved in:
Bibliographic Details
Title: Clinical Pharmacokinetic Assessment of Lazertinib in Healthy Adult Participants: Effects of GSTM1 Genotype.
Authors: Mehta J; Johnson & Johnson, Spring House, PA, USA. jmehta8@its.jnj.com., Thompson C; Johnson & Johnson, Spring House, PA, USA., Scheers E; Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium., Leclercq L; Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium., Jang SB; Yuhan Corporation, Seoul, Republic of Korea., Kim DK; Yuhan Corporation, Seoul, Republic of Korea., Haddish-Berhane N; Johnson & Johnson, Spring House, PA, USA., Hellemans P; Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium., Jiao JJ; Johnson & Johnson, Raritan, NJ, USA., Clemens PL; Johnson & Johnson, Spring House, PA, USA.
Source: Clinical drug investigation [Clin Drug Investig] 2025 Dec; Vol. 45 (12), pp. 935-944. Date of Electronic Publication: 2025 Oct 12.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41076618
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical Pharmacokinetic Assessment of Lazertinib in Healthy Adult Participants: Effects of GSTM1 Genotype.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mehta+J%22">Mehta J</searchLink>; Johnson & Johnson, Spring House, PA, USA. jmehta8@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Thompson+C%22">Thompson C</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Scheers+E%22">Scheers E</searchLink>; Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Leclercq+L%22">Leclercq L</searchLink>; Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Jang+SB%22">Jang SB</searchLink>; Yuhan Corporation, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DK%22">Kim DK</searchLink>; Yuhan Corporation, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Haddish-Berhane+N%22">Haddish-Berhane N</searchLink>; Johnson & Johnson, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hellemans+P%22">Hellemans P</searchLink>; Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Jiao+JJ%22">Jiao JJ</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Clemens+PL%22">Clemens PL</searchLink>; Johnson & Johnson, Spring House, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2025 Dec; Vol. 45 (12), pp. 935-944. <i>Date of Electronic Publication: </i>2025 Oct 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41076618
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40261-025-01494-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 935
    Titles:
      – TitleFull: Clinical Pharmacokinetic Assessment of Lazertinib in Healthy Adult Participants: Effects of GSTM1 Genotype.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mehta J
      – PersonEntity:
          Name:
            NameFull: Thompson C
      – PersonEntity:
          Name:
            NameFull: Scheers E
      – PersonEntity:
          Name:
            NameFull: Leclercq L
      – PersonEntity:
          Name:
            NameFull: Jang SB
      – PersonEntity:
          Name:
            NameFull: Kim DK
      – PersonEntity:
          Name:
            NameFull: Haddish-Berhane N
      – PersonEntity:
          Name:
            NameFull: Hellemans P
      – PersonEntity:
          Name:
            NameFull: Jiao JJ
      – PersonEntity:
          Name:
            NameFull: Clemens PL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1918
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Clinical drug investigation
              Type: main
ResultId 1